Author, year | Age | Sex | Site | Diagnosis | Metastasis | Ectopic pancreas | Therapeutic option | Adjuvant therapy | Outcome |
---|---|---|---|---|---|---|---|---|---|
Fukunaga, 2002 [2] | 77 | F | Fundus | MAEC | None | None | EMR | – | Alive, 7mo |
Sun et al., 2004 [3] | 86 | F | Antrum | ACC | None | None | partial gastrectomy | – | NM |
Jain et al., 2005 [5] | 41 | F | Body | MAEC | LN | None | partial gastrectomy, partial omentectomy | – | Alive, 2 yr |
61 | M | Fundus | MAEC | LN, Liver | None | subtotal gastrectomy | – | Dead, 6mo | |
72 | M | Body | MAEC | None | None | subtotal gastrectomy | – | Dead, 4mo | |
Mizuno et al., 2007 [6] | 73 | M | Pylorus | NAa | LN, Liver | None | pancreaticoduodenectomy | Gemcitabine+Cisplatin+ 5-FU | Alive, 11mo |
Ambrosini-Spaltro et al., 2009 [7] | 52 | M | Antrum | ACC | None | Presence | subtotal gastrectomy, omentectomy, cholecystectomy | NM | NM |
Kusafuka et al., 2009 [8] | 56 | F | Body | MAEC | Peritoneum, Liver, Skin | None | total gastrectomy, splenectomy, right-half colonectomy | S-1 + Cisplatin | Dead |
Coyne, 2012 [9] | 77 | F | Fundus | ACC | None | None | partial gastrectomy | – | Dead, 1mo |
Yonenaga et al., 2016 [10] | 67 | M | Body | MAEC | LN | None | distal gastrectomy, lymph node dissection | S-1 monotherapy | Alive, 21mo |
63 | M | Antrum | ACC | Liver | None | – | Gemcitabine+Erlotinib | Dead, 5mo | |
Kim et al., 2017 [11] | 54 | M | Cardia | ACC | None | None | laparoscopic wedge resection | – | Alive, 33mo |
Fujita et al., 2019 [12] | 67 | M | NM | MiNEN | None | None | ESD | – | Alive, 15mo |